Long-term safety evaluation of glucosamine as a dietary supplement is needed (beyond 3 years of usage).
All future trials should have a systematic collection, evaluation, and reporting of adverse events, and key data relevant to addressing the gaps in knowledge should be collected and reported.
The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Appendix E: Glucosamine: Prototype Monograph Summary ."
Dietary Supplements: A Framework for Evaluating Safety . Washington, DC: The National Academies Press,
Please select a format: